<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
        {font-family:"Cambria Math";
        panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
        {font-family:"\.AppleSystemUIFont";
        panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
        {font-family:UICTFontTextStyleEmphasizedBody;
        panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
        {font-family:UICTFontTextStyleBody;
        panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
        {font-family:UICTFontTextStyleItalicBody;
        panose-1:2 11 6 4 2 2 2 2 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin:0in;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
p.p1, li.p1, div.p1
        {mso-style-name:p1;
        margin:0in;
        font-size:13.0pt;
        font-family:"\.AppleSystemUIFont";}
p.p2, li.p2, div.p2
        {mso-style-name:p2;
        margin:0in;
        font-size:13.0pt;
        font-family:"\.AppleSystemUIFont";}
span.s1
        {mso-style-name:s1;
        font-family:UICTFontTextStyleEmphasizedBody;
        font-weight:bold;
        font-style:normal;}
span.s2
        {mso-style-name:s2;
        font-family:UICTFontTextStyleBody;
        font-weight:normal;
        font-style:normal;}
span.s3
        {mso-style-name:s3;
        font-family:UICTFontTextStyleBody;
        font-weight:normal;
        font-style:normal;
        text-decoration:underline;}
span.s4
        {mso-style-name:s4;
        font-family:UICTFontTextStyleEmphasizedBody;
        font-weight:bold;
        font-style:normal;
        text-decoration:underline;}
span.s5
        {mso-style-name:s5;
        font-family:UICTFontTextStyleItalicBody;
        font-weight:normal;
        font-style:italic;}
span.s6
        {mso-style-name:s6;
        font-weight:bold;
        font-style:italic;}
span.apple-converted-space
        {mso-style-name:apple-converted-space;}
span.EmailStyle28
        {mso-style-type:personal-reply;
        font-family:"Calibri",sans-serif;
        color:windowtext;}
.MsoChpDefault
        {mso-style-type:export-only;
        font-size:10.0pt;}
@page WordSection1
        {size:8.5in 11.0in;
        margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
        {page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72" style="word-wrap:break-word">
<div class="WordSection1">
<div style="border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0in 0in 0in">
<p class="MsoNormal"><b><span style="font-size:12.0pt;color:black">From: </span></b><span style="font-size:12.0pt;color:black">Sarah S Syed <sarahss@mit.edu><br>
<b>Subject: </b>Pathways in Biotech<o:p></o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
<p class="p1"><span class="s1">Are you interested in computational biology and/or drug development?</span><o:p></o:p></p>
<p class="p1"><span class="s1"> </span><o:p></o:p></p>
<p class="p1"><span class="s2">The MIT Biotech Group invites you to the </span><span class="s1">FINAL INSTALLMENT
</span><span class="s2">of:</span><span class="s1"> The Pathways in Biotech Seminar Series!</span><span class="s2"> Please join us
</span><span class="s3"><span style="text-decoration:none">on </span></span><span class="s4"><span style="text-decoration:none">Tuesday, May 3rd from 7-8 PM</span></span><span class="s1"> in Room 2-105
</span><span class="s2">for a seminar on </span><span class="s1">Computational Biology and Drug Development
</span><span class="s2">with </span><span class="s1">Dr. Joshua Apgar, </span><span class="s2">co-founder and CSO of
<a href="https://www.appliedbiomath.com/"><span class="s4"><span style="color:blue">Applied BioMath</span></span></a></span><span class="s1">!</span><o:p></o:p></p>
<p class="p2"><o:p> </o:p></p>
<p class="p1"><span class="s2">MBG’s Pathways in Biotech Series provides MIT undergrads with a deep dive into four major areas of biotech research and innovation. By interacting with our expert guest lecturers, you’ll learn about the
</span><span class="s5">science of biotech</span><span class="s2">, the </span><span class="s5">hottest trends in the biotech industry</span><span class="s2">, and the
</span><span class="s5">breadth of career paths</span><span class="s2"> available in the biotech space.</span><o:p></o:p></p>
<p class="p2"><o:p> </o:p></p>
<p class="p1"><span class="s6">Dr. Joshua Apgar</span><span class="s5"> is the Co-Founder and Chief Scientific Officer of Applied BioMath, which aims to revolutionize both the quality and economics of drug invention by applying Model-Informed Drug Discovery
 and Development techniques (MID3). Prior to this, Josh was a Principal Scientist in the Systems Biology Group of the Department of Immunology and Inflammation at Boehringer Ingelheim Pharmaceuticals. His work leveraged physics-based models to translate in
 vitro and in vivo data, assess target feasibility, understand drug mechanism of action, and predict human doses. The ultimate goal of this work was to reduce late-stage attrition in drug development through a deep and quantitative interrogation of drug pharmacology
 and disease pathophysiology. Josh received his PhD from MIT in Biological Engineering where he worked on experiment design for Systems Biology, focusing on the identification of tractable experiments that could allow for the estimation of unknown parameters
 and reveal complex mechanisms in signal transduction networks. Before that Josh worked at Avaki to develop a highly scalable software platform to support High Performance Computing, and Enterprise Information Integration in the Life Sciences, and Engineering.</span><span class="apple-converted-space"><i><span style="font-family:UICTFontTextStyleItalicBody"> </span></i></span><o:p></o:p></p>
<p class="p2"><o:p> </o:p></p>
<p class="p1"><span class="s2">First 20 attendees will get free food from Saloniki’s!!</span><o:p></o:p></p>
<p class="p1"><span class="s1">RSVP Here: <a href="https://mitbiotechgroup.typeform.com/to/NxxZx7uK">
<span class="s4"><span style="color:blue">https://mitbiotechgroup.typeform.com/to/NxxZx7uK</span></span></a><o:p></o:p></span></p>
<p class="p1"><span class="s1"><o:p> </o:p></span></p>
<p class="p1"><img border="0" width="815" height="1055" style="width:8.4895in;height:10.9895in" id="Picture_x0020_1" src="cid:image001.png@01D85DF6.173002B0" alt="Graphical user interface, text, chat or text message

Description automatically generated"><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
</body>
</html>